AI filmmaking is now a thing, and it's enabling creatives to share their ideas in new ways and with higher fidelity than ever ...

Quick question: how did you learn to code? It probably wasn’t bribing someone a year or two ahead of you in CS to finish all ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Hundreds of thousands of generators sold at retailers such as Costco, Lowe’s and Home Depot are being recalled due to serious safety hazards. According to warnings from the U.S. Consumer Product ...

Nearly 150,000 generators sold at stores like Home Depot and Lowe’s are being recalled for posing a deadly fire hazard. According to an April 16 warning from the U.S. Consumer Product Safety ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...